Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178) registering the offer and sale of the Securities filed with the Commission on May 24, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 4 contracts
Sources: Underwriting Agreement (ParaZero Technologies Ltd.), Underwriting Agreement (ParaZero Technologies Ltd.), Underwriting Agreement (ParaZero Technologies Ltd.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178264073) registering the offer and sale of the Securities filed with Shares submitted to the Commission on May 24[●], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 4 contracts
Sources: Underwriting Agreement (Elate Group, Inc.), Underwriting Agreement (Elate Group, Inc.), Underwriting Agreement (Elate Group, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178262835) registering the offer and sale of the Securities filed with the Commission on May 24February 18, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 3 contracts
Sources: Underwriting Agreement (Jeffs' Brands LTD), Underwriting Agreement (Jeffs' Brands LTD), Underwriting Agreement (Jeffs' Brands LTD)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178269419) registering the offer and sale of the Securities filed with submitted to the Commission on May 24January 26, 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 3 contracts
Sources: Underwriting Agreement (Hanryu Holdings, Inc.), Underwriting Agreement (Hanryu Holdings, Inc.), Underwriting Agreement (Hanryu Holdings, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178262167) registering the offer and sale of the Securities filed with submitted to the Commission on May 24January 14, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 3 contracts
Sources: Underwriting Agreement (Infinite Group Inc), Underwriting Agreement (Infinite Group Inc), Underwriting Agreement (Infinite Group Inc)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178284448) registering the offer and sale of the Securities filed with submitted to the Commission on May January 24, 2022 2025 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 3 contracts
Sources: Underwriting Agreement (Digital Ally, Inc.), Underwriting Agreement (Digital Ally, Inc.), Underwriting Agreement (Digital Ally, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-3 (File No. 333-265178269644) registering the offer and sale of the Offered Securities filed with submitted to the Commission on May 24February 8, 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Sources: Underwriting Agreement (Volcon, Inc.), Underwriting Agreement (Volcon, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178265900) registering the offer and sale of the Securities filed with submitted to the Commission on May 24June 29, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Sources: Underwriting Agreement (Clearmind Medicine Inc.), Underwriting Agreement (Clearmind Medicine Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178) Registration Statement registering the offer and sale of the Securities filed with submitted to the Commission on May 24December 13, 2022 2024 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Sources: Underwriting Agreement (Super League Enterprise, Inc.), Underwriting Agreement (Super League Enterprise, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178[●]) registering the offer and sale of the Securities filed with submitted to the Commission on May 24[DATE], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Sources: Underwriting Agreement (Wearable Devices Ltd.), Underwriting Agreement (Wearable Devices Ltd.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178[●]) registering the offer and sale of the Securities filed with submitted to the Commission on May 24[DATE], 2022 2021 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Sources: Underwriting Agreement (Maris Tech Ltd.), Underwriting Agreement (Maris Tech Ltd.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178264339) registering the offer and sale of the Securities filed with submitted to the Commission on May 24April 15, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Sources: Underwriting Agreement (Curative Biotechnology Inc), Underwriting Agreement (Curative Biotechnology Inc)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178274800) registering the offer and sale of the Offered Securities filed with submitted to the Commission on May 24September 29, 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Sources: Underwriting Agreement (Volcon, Inc.), Underwriting Agreement (Volcon, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178265969) registering the offer and sale of the Securities filed with submitted to the Commission on May 24July 1, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Sources: Underwriting Agreement (Bruush Oral Care Inc.), Underwriting Agreement (Bruush Oral Care Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178262838) registering the offer and sale of the Securities filed with the Commission on May 24February 18, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Sources: Underwriting Agreement (Wearable Devices Ltd.), Underwriting Agreement (Wearable Devices Ltd.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178267206) registering the offer and sale of the Securities filed with submitted to the Commission on May 24August 31, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Sources: Underwriting Agreement (Avenue Therapeutics, Inc.), Underwriting Agreement (Avenue Therapeutics, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178) registering the offer and sale of the Securities filed with Shares submitted to the Commission on May 24, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Sources: Underwriting Agreement (ParaZero Technologies Ltd.), Underwriting Agreement (ParaZero Technologies Ltd.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178276556) registering the offer and sale of the Securities filed with submitted to the Commission on May 24January 17, 2022 2024 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Sources: Underwriting Agreement (Cemtrex Inc), Underwriting Agreement (Cemtrex Inc)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178269027) registering the offer and sale of the Securities filed with Shares submitted to the Commission on May 24[●], 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178333-[●]) registering the offer and sale of the Securities filed with submitted to the Commission on May 24, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Sources: Underwriting Agreement (Lixte Biotechnology Holdings, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178263715) registering the offer and sale of the Securities filed with submitted to the Commission on May 24March 18, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178263715) registering the offer and sale of the Securities filed with submitted to the Commission on May 24[DATE], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178264339) registering the offer and sale of the Securities filed with submitted to the Commission on May 24April 15, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Sources: Underwriting Agreement (Curative Biotechnology Inc)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178333-[●]) registering the offer and sale of the Securities filed with submitted to the Commission on May 24, 2022 [●] and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 F-3 (File No. 333-265178274841) registering the offer and sale of the Securities filed with the Commission on May 24October 3, 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178333-[●]) registering the offer and sale of the Securities filed with Shares submitted to the Commission on May 24[●], 2022 2024 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178265400) registering the offer and sale of the Securities filed with submitted to the Commission on May 24[DATE], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178264073) registering the offer and sale of the Securities filed with Shares submitted to the Commission on May 24April 1, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178271377) registering the offer and sale of the Securities filed with submitted to the Commission on May 24April 21, 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Sources: Underwriting Agreement (XJet Ltd.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178333-[●]) registering the offer and sale of the Securities filed with submitted to the Commission on May 24, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Sources: Underwriting Agreement (Bynd Cannasoft Enterprises Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178333-[●]) registering the offer and sale of the Securities filed with submitted to the Commission on May 24[●], 2022 2024 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178288120) registering the offer and sale of the Securities filed with submitted to the Commission on May 24, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Sources: Placement Agent Agreement (Lixte Biotechnology Holdings, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178265400) registering the offer and sale of the Securities filed with submitted to the Commission on May 24June 3, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178280253) registering the offer and sale of the Securities filed with submitted to the Commission on May 24June 17, 2022 2024 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178260670) registering the offer and sale of the Securities filed with submitted to the Commission on May 24[DATE], 2022 2021 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178333-[●]) registering the offer and sale of the Securities filed with submitted to the Commission on May 24June 11, 2022 2025 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178333-[●]) registering the offer and sale of the Securities filed with Shares submitted to the Commission on May 24[●], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 (File No. 333-265178333-[●]) registering the offer and sale of the Securities filed with submitted to the Commission on May 24[DATE], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form F-1 S-1 (File No. 333-265178333-[●]) registering the offer and sale of the Securities filed with submitted to the Commission on May 24[●], 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract